Added to YB: 2025-06-20
Pitch date: 2025-06-17
HIMS [neutral]
Hims & Hers Health, Inc.
-66.39%
current return
Author Info
Company Info
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
Market Cap
$3.7B
Pitch Price
$60.48
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.69
P/E
32.11
EV/Sales
1.83
Sector
Health Care Providers and Services
Category
N/A
HIMS: Another (Misleading) GLP-1 PR Claim
HIMS (update - short): Personalized GLP-1 program shows 60% retention at 3 months, worse than commercial Wegovy's 70% in JPM/Gleason data. CEO Dudum misleadingly claims superior outcomes vs BCBS study. Concerning: 90k personalized users signals potential mass prescribing, which may violate compounding laws. Regulatory/Novo inaction puzzling.
Read full article (9 min)